common.study.topics.clinical

Probiotics and Multi-Drug Resistant Urinary Tract Infection

common.study.values.description

Probiotics and Multi-Drug Resistant Urinary Tract Infection

This pilot study is a single-site randomized, double blinded placebo-controlled in females with recurrent multi-drug resistant (MDR) urinary tract infections(UTI). Our study hypothesizes that a novel probiotic strain improves antibiotic sensitivity patterns in these former MDR UTIs.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - Antibiotics

Per Infectious Disease Society guidelines for Antimicrobial treatment of uncomplicated cystitis and pyelonephritis in women

Dietary Supplement - Bifidobacterium infantis

Probiotics

Placebo

Sugar pill manufactured to mimic probiotic tablet

participant.views.study.view.additional

participant.views.study.view.scientific-title

Probiotic and Effects on Multi-Drug Resistant Urinary Tract Infection

common.study.values.clinical-trial-id

NCT03644966

participant.views.study.view.id

dyPoPb